looks like we won the battle, but haven't won the war quite yet. I expect the rumour mill we be starting back up very soon, with reports of Denner being followed in the mens room at Ariad by some senior exec at Pfizer. After todays news, what follows is almost an anticlimax, except that the shorts aren't going to let the sp up quickly which would cause a panic in their ranks. First bit of business is for Denner to announce that the Berger plan for profitability is now making its away along the sewer system of Cambridge and that 113 will not be partnered away. Then to finally announce the new molecule if there is one, another bit of uncertainty that needs to go away. At least we wont have to watch Berger on television anymore, sweating profusely as he struggles to remember the new address of corporate headquarters.... does Ponatinib work for that problem?
